Science and Technology Committee (Commons)

Regenerative medicine inquiry

Inquiry status: open

Oral evidence concluded. Report in preparation.

Scope of the inquiry

The Science and Technology Committee is undertaking an inquiry into regenerative medicine. Regenerative medicine (or advanced therapies) involves replacing or regenerating cells, tissues or organs in order to restore or establish normal function in people with chronic illnesses. It has been used, for example, in bone marrow transplants and offers the prospect of more effective repairs for faulty hearts, skin burns and worn-out joints. Regenerative medicine includes cell therapy, gene therapy, tissue engineering and other methods.

Terms of reference: Regenerative medicine

Latest evidence

  • 07 Dec 2016 - Regenerative medicine - oral evidence | PDF version (PDF289 KB) HC 275 | Published 15 Dec 2016

    Evidence given by Dr Nick Crabb, Programme Director, Scientific Affairs, National Institute for Health and Care Excellence, Dr Jonathan Fielden, Director of Specialised Commissioning and Deputy National Medical Director, NHS England, and Dr James Palmer, Clinical Director of Specialised Commissioning, NHS England; Professor Amit Nathwani, Professor of Haematology, Royal Free Hospital, Professor Giovanna Lombardi, Professor of Human Transplant Immunology, King’s College London, and Dr Anthony Mathur, Professor of Cardiology, Queen Mary’s School of Medicine and Dentistry; Lord Prior of Brampton, Parliamentary Under-Secretary of State for Health, Department of Health

    Watch this evidence session

Next meeting(s)

There are currently no public meetings scheduled.

Receive RSS updates

Share this page